Company / Operating Income
OptimizeRx Corp Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$13.7M
FY2025
5-year range
-$26.4M / $361.1K
FY2021-FY2025
Trend
+48.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2025 after 2 years of decline, reaching -$14M.
Based on SEC 10-K filings.
-$14M in FY2025.
Declined from -$12M to -$14M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 48.1% year-over-year.
- Peak operating income was recorded in FY2022.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.7M | +48.1% |
| FY2024 | -$26.4M | -114.8% |
| FY2023 | -$12.3M | -3503.7% |
| FY2022 | $361.1K | +116.9% |
| FY2021 | -$2.1M | +42.2% |
| FY2020 | -$3.7M | -2150.5% |
| FY2019 | $180.1K | +108.5% |
| FY2018 | -$2.1M | -34.7% |
| FY2017 | -$1.6M | -164.7% |
| FY2016 | -$597.4K | +41.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026